LRG1 mRNA Expression in Breast Cancer Associates With PIK3CA Genotype and With Aromatase Inhibitor Therapy Outcome

Molecular Oncology - Netherlands
doi 10.1016/j.molonc.2016.07.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Performance of FRAX in Women With Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry‐Based Cohort Study

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Random-Start Ovarian Stimulation With Aromatase Inhibitor for Fertility Preservation in Women With Japanese Breast Cancer

Reproductive Medicine and Biology
Reproductive MedicineCell Biology
2019English

Sequential Changes in Gene Expression Profiles in Breast Cancers During Treatment With the Aromatase Inhibitor, Letrozole

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

PIK3CA Mutation Predicts Resistance to Breast Cancer Therapy

Cancer Discovery
Oncology
2013English

Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Aromatase Inhibitor Associated Musculoskeletal Symptoms Are Associated With Reduced Physical Activity Among Breast Cancer Survivors

Breast Journal
Internal MedicineSurgeryOncology
2013English

PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care
SurgeryOncology
2010English

A Polymorphism in the TC21 Promoter Associates With an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer

Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy